Cargando…

Distinct Responsiveness of Tumor-Associated Macrophages to Immunotherapy of Tumors with Different Mechanisms of Major Histocompatibility Complex Class I Downregulation

SIMPLE SUMMARY: Tumor-associated macrophages (TAMs) are one of the major cell subpopulations in the tumor microenvironment (TME) where they can either be pro-tumorigenic or contribute to an anti-tumor immunity. The TME and TAM phenotype were analyzed after combined immuno-therapy (IT) in tumor model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piatakova, Adrianna, Polakova, Ingrid, Smahelova, Jana, Johari, Shweta Dilip, Nunvar, Jaroslav, Smahel, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235485/ https://www.ncbi.nlm.nih.gov/pubmed/34205330 http://dx.doi.org/10.3390/cancers13123057

Ejemplares similares

Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation
por: Grzelak, Adrianna, et al.
Publicado: (2018)

CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade
por: Vackova, Julie, et al.
Publicado: (2021)

Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade
por: Vackova, Julie, et al.
Publicado: (2020)

Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses
por: Smahel, Michal, et al.
Publicado: (2023)

ARG1 mRNA Level Is a Promising Prognostic Marker in Head and Neck Squamous Cell Carcinomas
por: Pokrývková, Barbora, et al.
Publicado: (2021)

PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression
por: Šmahel, Michal
Publicado: (2017)

Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors
por: Poláková, Ingrid, et al.
Publicado: (2019)

Aspartate β-hydroxylase as a target for cancer therapy
por: Kanwal, Madiha, et al.
Publicado: (2020)

Lack of Conserved miRNA Deregulation in HPV-Induced Squamous Cell Carcinomas
por: Nunvar, Jaroslav, et al.
Publicado: (2021)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
por: Janelle, Valérie, et al.
Publicado: (2020)

Systemic Administration of CpG Oligodeoxynucleotide and Levamisole as Adjuvants for Gene-Gun-Delivered Antitumor DNA Vaccines
por: Šmahel, Michal, et al.
Publicado: (2011)

Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation
por: Fares, Suzan, et al.
Publicado: (2019)

Altered transcription of genes coding for class I histocompatibility antigens in murine tumor cells
Publicado: (1983)

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice
Publicado: (1995)

Relationship between Major Histocompatibility Complex Class I Expression and Prognosis in Canine Mammary Gland Tumors
por: TANAKA, Toshiyuki, et al.
Publicado: (2013)

Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules
Publicado: (1994)

Feasibility of Real-time Behavior Monitoring Via Mobile Technology in Czech Adults Aged 50 Years and Above: 12-Week Study With Ecological Momentary Assessment
por: Elavsky, Steriani, et al.
Publicado: (2021)

Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages
por: Yotsumoto, Karen, et al.
Publicado: (2020)

Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection
por: Gameiro, Steven F., et al.
Publicado: (2017)

Detailed Characteristics of Tonsillar Tumors with Extrachromosomal or Integrated Form of Human Papillomavirus
por: Pokrývková, Barbora, et al.
Publicado: (2019)

“Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma
por: Liu, Kevin X., et al.
Publicado: (2020)

Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes
Publicado: (1995)

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
por: Wieczorek, Marek, et al.
Publicado: (2017)

Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens
Publicado: (1986)

Two Distinct Pathways Mediated by PA28 and hsp90 in Major Histocompatibility Complex Class I Antigen Processing
por: Yamano, Taketoshi, et al.
Publicado: (2002)

Major histocompatibility complex class II expression distinguishes two distinct B cell developmental pathways during ontogeny
Publicado: (1994)

Downregulation of Cell Surface Major Histocompatibility Complex Class I Expression Is Mediated by the Left-End Transcription Unit of Fowl Adenovirus 9
por: Griffin, Bryan D., et al.
Publicado: (2021)

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
por: Ossendorp, Ferry, et al.
Publicado: (1998)

Second Class Minors: Molecular Identification of the Autosomal H46 Histocompatibility Locus as a Peptide Presented by Major Histocompatibility Complex Class II Molecules
por: Sahara, Hiroeki, et al.
Publicado: (2003)

Expression Regulation of Major Histocompatibility Complex Class I and Class II Encoding Genes
por: van den Elsen, Peter J.
Publicado: (2011)

Evolution of major histocompatibility complex class I and class II genes in the brown bear
por: Kuduk, Katarzyna, et al.
Publicado: (2012)

Chapter 7 IFN Inducibility of Major Histocompatibility Antigens in Tumors
por: Seliger, Barbara, et al.
Publicado: (2008)

Growth-inhibitory Activity and Downregulation of the Class II Tumor-suppressor Gene H-rev107 in Tumor Cell Lines and Experimental Tumors
por: Sers, Christine, et al.
Publicado: (1997)

Hypoxemic Bronchiolitis Related to Major Histocompatibility Class II Deficiency
por: Hammami, S., et al.
Publicado: (2013)

The Marine Mammal Class II Major Histocompatibility Complex Organization
por: de Sá, André Luiz Alves, et al.
Publicado: (2019)

Major histocompatibility complex Class II-based therapy for stroke
por: Gonzales-Portillo, Bella M., et al.
Publicado: (2021)

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products
Publicado: (1995)

Establishment of tumor inflammasome clusters with distinct immunogenomic landscape aids immunotherapy
por: Liang, Qingyu, et al.
Publicado: (2021)

Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-γ and tumor necrosis factor-α
por: Vidovic, Maria, et al.
Publicado: (1990)

Modulation of the Major Histocompatibility Complex Class II–Associated Peptide Repertoire by Human Histocompatibility Leukocyte Antigen (Hla)-Do
por: van Ham, Marieke, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_pkofg269o01kt37s3v23mnh27c